• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NUP98/HOXA9融合转录本在伴有t(7;11)(p15;p15)的费城染色体阳性慢性髓性白血病急变期的表达

Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15).

作者信息

Yamamoto K, Nakamura Y, Saito K, Furusawa S

机构信息

Department of Haematology, Dokkyo University School of Medicine, Tochigi, Japan.

出版信息

Br J Haematol. 2000 May;109(2):423-6. doi: 10.1046/j.1365-2141.2000.02003.x.

DOI:10.1046/j.1365-2141.2000.02003.x
PMID:10848835
Abstract

The t(7;11)(p15;p15) translocation is a recurrent aberration observed in acute myeloblastic leukaemia (AML) and chronic myelogenous leukaemia (CML). It has been shown that the NUP98 gene at 11p15 is fused with the HOXA9 gene at 7p15 in AML with t(7;11). We report the first case with CML expressing the NUP98/HOXA9 fusion transcript. A 27-year-old Japanese man was initially diagnosed as in the chronic phase of Philadelphia-positive CML. At the diagnosis of myeloid blast crisis, the karyotype evolved to 46, XY, t(7;11)(p15;p15), t(9;22)(q34;q11). Reverse transcriptase polymerase chain reaction identified the NUP98/HOXA9 transcript, suggesting that the NUP98/HOXA9 fusion protein could play a critical role in the progression to blast crisis.

摘要

t(7;11)(p15;p15)易位是在急性髓细胞白血病(AML)和慢性粒细胞白血病(CML)中观察到的一种常见畸变。研究表明,在伴有t(7;11)的AML中,位于11p15的NUP98基因与位于7p15的HOXA9基因融合。我们报告了首例表达NUP98/HOXA9融合转录本的CML病例。一名27岁的日本男性最初被诊断为费城染色体阳性CML的慢性期。在诊断为髓系原始细胞危象时,核型演变为46, XY, t(7;11)(p15;p15), t(9;22)(q34;q11)。逆转录聚合酶链反应鉴定出NUP98/HOXA9转录本,提示NUP98/HOXA9融合蛋白可能在进展为原始细胞危象中起关键作用。

相似文献

1
Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15).NUP98/HOXA9融合转录本在伴有t(7;11)(p15;p15)的费城染色体阳性慢性髓性白血病急变期的表达
Br J Haematol. 2000 May;109(2):423-6. doi: 10.1046/j.1365-2141.2000.02003.x.
2
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.一种由BCR/ABL与NUP98/HOXA9协同作用诱导的慢性粒细胞白血病急变期小鼠模型。
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7622-7. doi: 10.1073/pnas.102583199.
3
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia.NUP98基因重排与慢性粒细胞白血病的克隆进化
Genes Chromosomes Cancer. 2001 Apr;30(4):410-5. doi: 10.1002/1098-2264(2001)9999:9999<::aid-gcc1108>3.0.co;2-9.
4
The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.急性髓系白血病中的染色体易位t(7;11)(p15;p15)导致NUP98基因与HOXA簇基因HOXA13融合,但不与HOXA9融合。
Genes Chromosomes Cancer. 2002 Aug;34(4):437-43. doi: 10.1002/gcc.10077.
5
Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).单易位和双嵌合转录本:在伴有染色体易位t(7;11)(p15;p15)导致HOXA11或HOXA13断裂的髓系白血病中检测NUP98-HOXA9
Blood. 2002 Feb 15;99(4):1428-33. doi: 10.1182/blood.v99.4.1428.
6
A case of acute myeloid leukemia with t(7;11)(p15;p15) mimicking myeloid crisis of chronic myelogenous leukemia.
Int J Hematol. 2002 Jul;76(1):80-3. doi: 10.1007/BF02982723.
7
t(7;11)(p15;p15) Chronic myeloid leukaemia developed into blastic transformation showing a novel NUP98/HOXA11 fusion.t(7;11)(p15;p15) 慢性髓性白血病进展为原始细胞转化,显示一种新的NUP98/HOXA11融合。
Br J Haematol. 2002 Jan;116(1):170-2. doi: 10.1046/j.1365-2141.2002.03246.x.
8
Molecular heterogeneity of the NUP98/HOXA9 fusion transcript in myelodysplastic syndromes associated with t(7;11)(p15;p15).与t(7;11)(p15;p15)相关的骨髓增生异常综合征中NUP98/HOXA9融合转录本的分子异质性
Br J Haematol. 1999 Dec;107(3):600-4. doi: 10.1046/j.1365-2141.1999.01754.x.
9
Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis.通过配对测序对一名慢性髓性白血病患者的荧光原位杂交假阳性结果进行特征分析及向髓母细胞危象进展情况的研究。
Cancer Genet. 2020 May;243:48-51. doi: 10.1016/j.cancergen.2020.02.008. Epub 2020 Mar 17.
10
A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).一种编码假定RNA结合蛋白的新基因MSI2,在慢性髓性白血病疾病进展过程中反复发生重排,并由于隐匿性t(7;17)(p15;q23)而与HOXA9形成融合基因。
Cancer Res. 2003 Mar 15;63(6):1202-6.

引用本文的文献

1
Elevated Lactate in the AML Bone Marrow Microenvironment Polarizes Leukemia-Associated Macrophages via GPR81 Signaling.急性髓系白血病骨髓微环境中升高的乳酸通过GPR81信号传导使白血病相关巨噬细胞极化。
bioRxiv. 2025 Mar 6:2023.11.13.566874. doi: 10.1101/2023.11.13.566874.
2
Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study.伴有 t(7;11)(p15;p15) 易位的髓系肿瘤患者的临床特征和预后:一项单中心回顾性研究。
BMC Cancer. 2024 Aug 5;24(1):955. doi: 10.1186/s12885-024-12679-8.
3
Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia.
鉴定Musashi2易位作为髓系白血病中的一种新型致癌基因。
bioRxiv. 2023 Dec 29:2023.12.29.573601. doi: 10.1101/2023.12.29.573601.
4
Liquid‒liquid phase separation: roles and implications in future cancer treatment.液液相分离:在未来癌症治疗中的作用和意义。
Int J Biol Sci. 2023 Aug 6;19(13):4139-4156. doi: 10.7150/ijbs.81521. eCollection 2023.
5
Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.慢性髓性白血病患者的分子、细胞遗传学和血液学分析以及两种新型易位的发现
Anal Cell Pathol (Amst). 2021 Aug 12;2021:4909012. doi: 10.1155/2021/4909012. eCollection 2021.
6
A Recurrent Cryptic Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS.一名成年混合表型急性白血病(T/髓系,未另行分类)患者的复发性隐匿重排
Front Oncol. 2021 Jul 22;11:690218. doi: 10.3389/fonc.2021.690218. eCollection 2021.
7
Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.NUP98 重排血液系统恶性肿瘤的机制见解和潜在治疗方法。
Blood. 2020 Nov 12;136(20):2275-2289. doi: 10.1182/blood.2020007093.
8
ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.ADAM8 是由患者来源的诱导多能干细胞鉴定的酪氨酸激酶抑制剂耐药性慢性髓系白血病细胞的抗原。
Stem Cell Reports. 2018 Mar 13;10(3):1115-1130. doi: 10.1016/j.stemcr.2018.01.015. Epub 2018 Feb 8.
9
Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.髓系白血病干扰素-γ预处理的不同要求决定移植物抗白血病的抗性和敏感性。
J Clin Invest. 2017 Jun 30;127(7):2765-2776. doi: 10.1172/JCI85736. Epub 2017 Jun 12.
10
Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.与染色质预结合的Crm1招募Nup98-HoxA9融合蛋白以诱导Hox基因簇的异常表达。
Elife. 2016 Jan 7;5:e09540. doi: 10.7554/eLife.09540.